BioMaxima S.A. (WSE:BMX)

BioMaxima Revenue

BioMaxima had revenue of 14.12M PLN in the quarter ending March 31, 2026, a decrease of -7.61%. This brings the company's revenue in the last twelve months to 59.74M, up 5.55% year-over-year. In the year 2025, BioMaxima had annual revenue of 60.90M with 15.24% growth.

• Revenue (ttm): 59.74M
• Revenue Growth: +5.55%
• P/S Ratio: 0.71
• Revenue / Employee: 417.77K
• Employees: 143
• Market Cap: 42.52M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	60.90M	8.05M	15.24%
Dec 31, 2024	52.85M	6.07M	12.96%
Dec 31, 2023	46.79M	-97.08M	-67.48%
Dec 31, 2022	143.87M	64.78M	81.91%
Dec 31, 2021	79.09M	16.10M	25.57%
Dec 31, 2020	62.99M	32.51M	106.69%
Dec 31, 2019	30.47M	-2.18M	-6.69%
Dec 31, 2018	32.66M	-298.10K	-0.90%
Dec 31, 2017	32.96M	3.72M	12.72%
Dec 31, 2016	29.24M	6.15M	26.65%
Dec 31, 2015	23.08M	1.44M	6.64%
Dec 31, 2014	21.65M	-169.64K	-0.78%
Dec 31, 2013	21.82M	-693.86K	-3.08%
Dec 31, 2012	22.51M	12.00M	114.14%
Dec 31, 2011	10.51M	3.32M	46.25%
Dec 31, 2010	7.19M	507.17K	7.59%
Dec 31, 2009	6.68M	471.00K	7.58%
Dec 31, 2008	6.21M	-	-

Data Source: Fiscal.ai Last updated: May 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 22, 2026

Data Sources Report a data error